BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30521014)

  • 1. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
    An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
    Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
    Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
    J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
    Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
    Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
    Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
    Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
    Wu Y; Zhang J; Wang Y; Wang T; Han Q; Guo R; Zhang R; Ren H; Zhu Y; Xu H; Li L; Tong N; Liu F
    J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
    Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
    Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression.
    Zhang J; Xiao X; Wu Y; Yang J; Zou Y; Zhao Y; Yang Q; Liu F
    Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE ASSOCIATION OF SERUM BILIRUBIN ON KIDNEY CLINICOPATHOLOGIC FEATURES AND RENAL OUTCOME IN PATIENTS WITH DIABETIC NEPHROPATHY: A BIOPSY-BASED STUDY.
    Wu Y; Zhang J; Wang J; Wang Y; Han Q; Li H; Wang T; Liu F
    Endocr Pract; 2019 Jun; 25(6):554-561. PubMed ID: 30865534
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal histologic changes and the outcome in patients with diabetic nephropathy.
    An Y; Xu F; Le W; Ge Y; Zhou M; Chen H; Zeng C; Zhang H; Liu Z
    Nephrol Dial Transplant; 2015 Feb; 30(2):257-66. PubMed ID: 25063425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
    Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
    J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
    Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
    Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
    Wu Y; Liu F
    J Diabetes Complications; 2022 Aug; 36(8):108235. PubMed ID: 35853763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
    Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
    Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.